Clinical and radiologic outcomes of Lima ProMade custom 3D-printed glenoid components in primary and revision reverse total shoulder arthroplasty with severe glenoid bone loss: a minimum 2-year follow-up

被引:4
|
作者
Rashid, Mustafa S. [1 ]
Cunningham, Lindsay [1 ]
Shields, David W. [1 ]
Walton, Michael J. [1 ]
Monga, Puneet [1 ]
Bale, Richard S. [1 ]
Trail, Ian A. [1 ]
机构
[1] Wrightington Hosp, Dept Orthopaed Surg, Wigan, Lancs, England
关键词
Custom; 3D-printed; complex; shoulder; replacement; arthroplasty; revision; HEMIARTHROPLASTY;
D O I
10.1016/j.jse.2023.04.020
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: The purpose of this study is to report the clinical and radiologic outcomes of patients undergoing primary or revision reverse total shoulder arthroplasty using custom 3D-printed components to manage severe glenoid bone loss with a minimum of 2-year follow-up.Methods: Following ethical approval, patients were identified and invited to participate. Inclusion criteria were (1) severe glenoid bone loss necessitating the need for custom implants and (2) patients with definitive glenoid and humeral components implanted more than 2 years prior. Included patients underwent clinical assessment using the Oxford Shoulder Score (OSS), Constant-Murley score, American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), and the quick Disabilities of the Arm, Shoulder, and Hand questionnaire (QuickDASH). Radiographic assessment included anteroposterior and axial projections. Patients were invited to attend a computed tomography (CT) scan to confirm osseointegration. Statistical analysis used descriptive statistics (mean and standard deviation [SD]) and paired t test for parametric data.Results: Eleven patients declined to participate. Five patients were deceased prior to study commencement, leaving 42 remaining pa-tients in this analysis. Three patients had revision surgery before the 2-year follow-up; of these, 2 retained their custom glenoid com-ponents. Mean follow-up was 31.6 months from surgery (range 24-52 months). All 4 scores improved: OSS from a mean 15 (SD 8.4) to 36 (SD 12) (P < .001), Constant-Murley score from a mean 15 (SD 11.2) to 52 (SD 20.1) (P < .001), QuickDASH from a mean 70 (SD 21) to 31 (SD 24.8) (P = .004), and the ASES score from a mean 22 (SD 17.8) to 71 (SD 23.3) (P = .007). Radiologic evaluation demonstrated good osseointegration in all but 1 included patient.Conclusion: The utility of custom 3D-printed components for managing severe glenoid bone loss in primary and revision reverse total shoulder arthroplasty yields significant clinical improvements in this complex cohort. Large complex glenoid bone defects can be managed successfully with custom 3D-printed glenoid components.
引用
收藏
页码:2017 / 2026
页数:10
相关论文
共 48 条
  • [1] Reconstruction of recurrent shoulder dislocation with glenoid bone defect with 3D-printed titanium alloy pad: outcomes at 2-year minimum follow-up
    Huang, Danlei
    Ye, Zhiyang
    Wang, Jun
    Chen, Feixiong
    Liu, Haoyuan
    Huang, Jianming
    BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [2] Reconstruction of recurrent shoulder dislocation with glenoid bone defect with 3D-printed titanium alloy pad: outcomes at 2-year minimum follow-up
    Danlei Huang
    Zhiyang Ye
    Jun Wang
    Feixiong Chen
    Haoyuan Liu
    Jianming Huang
    BMC Musculoskeletal Disorders, 25
  • [3] Early clinical and radiographic outcomes of anatomic total shoulder arthroplasty with a biconvex posterior augmented glenoid for patients with posterior glenoid erosion: minimum 2-year follow-up
    Garrigues, Grant E.
    Quigley, Ryan J.
    Johnston, Peter S.
    Spencer, Edwin
    Walch, Gilles
    Neyton, Lionel
    Kelly, James
    Schrumpf, Mark
    Gillespie, Robert
    Sears, Benjamin W.
    Hatzidakis, Armodios M.
    Lau, Brian
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2022, 31 (08) : 1729 - 1737
  • [4] The radiographic and clinical outcomes of stemless reverse total shoulder arthroplasty: a minimum 2-year follow-up study
    Choi, Chang-Hyuk
    Choi, Ji Hoon
    Che, Sug Hun
    Kim, Jun-Young
    CLINICS IN SHOULDER AND ELBOW, 2024, 27 (04): : 428 - 436
  • [5] Hip-inspired implant for revision of failed reverse shoulder arthroplasty with severe glenoid bone loss Improved clinical outcome in 11 patients at 3-year follow-up
    Uri, Ofir
    Bayley, Ian
    Lambert, Simon
    ACTA ORTHOPAEDICA, 2014, 85 (02) : 171 - 176
  • [6] Results of total shoulder arthroplasty with a monoblock porous tantalum glenoid component: a prospective minimum 2-year follow-up study
    Budge, Matthew D.
    Nolan, Elizabeth M.
    Heisey, Meredith H.
    Baker, Kevin
    Wiater, J. Michael
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2013, 22 (04) : 535 - 541
  • [7] Clinical and radiographic outcomes following anatomic total shoulder arthroplasty utilizing an inset glenoid component at 2-year minimum follow-up: a dual center study
    Johnston, Peter S.
    Strony, John T.
    Churchill, Jessica L.
    Kankaria, Roma
    Sears, Benjamin W.
    Garrigues, Grant E.
    Gillespie, Robert J.
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2023, 32 (06) : 1222 - 1230
  • [8] Clinical Outcomes Following Revision Total Knee Arthroplasty: Minimum 2-Year Follow-up
    Quinn, Jonathan
    Jones, Peter
    Randle, Ray
    CLINICS IN ORTHOPEDIC SURGERY, 2022, 14 (01) : 69 - 75
  • [9] Arthroscopic Implant-Free Bone Grafting for Shoulder Instability With Glenoid Bone Loss: Clinical and Radiological Outcome at a Minimum 2-Year Follow-up
    Anderl, Werner
    Pauzenberger, Leo
    Laky, Brenda
    Kriegleder, Bernhard
    Heuberer, Philipp R.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2016, 44 (05): : 1137 - 1145
  • [10] Stemless reverse shoulder arthroplasty: clinical and radiologic outcomes with minimum 2 years' follow-up
    Nabergoj, Marko
    Ladermann, Alexandre
    Authom, Thierry
    Beaudouin, Emmanuel
    Azar, Michel
    Wahab, Hassan
    Leger, Olivier
    Haight, Harrison
    Harris, Howard
    Collin, Philippe
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2023, 32 (09) : e464 - e474